SeaStar Medical Holding (ICU) EBITDA Margin (2024 - 2026)
SeaStar Medical Holding's (ICU) quarterly EBITDA Margin came in at 616.42% in Q2 2026, down 9690.0% on a YoY basis from 6.43% in Q2 2025, and up 14.46% quarter-over-quarter from 720.6% in Q1 2026.
Powered by 
Analysis
SeaStar Medical Holding (ICU) EBITDA Margin (2024 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has reported EBITDA Margin for 3 consecutive years, with 616.42% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBITDA Margin fell 9690.0% year-over-year to 616.42%; the trailing twelve-month figure through Jun 2026 stood at 814.26% (up 110049.0% YoY), and the FY2025 full-year result was 986.63%, up 1222967.0% from the prior year.
- EBITDA Margin climbed to 616.42% in Q2 2026 per ICU's latest filing, from 720.6% in the prior quarter.
- Across five years, EBITDA Margin topped out at 519.53% in Q2 2025 and bottomed at 7114.93% in Q4 2024.
- Historically, EBITDA Margin has averaged 2434.03% across 3 years, with a median of 997.3% in 2026.
- The sharpest annual moves came in 2025 and 2026: EBITDA Margin jumped 639683 bps in 2025, then sank 9690 bps in 2026.
- Over 3 years, EBITDA Margin stood at 7114.93% in 2024, then jumped by 90 bps to 718.1% in 2025, then rose by 14 bps to 616.42% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 616.42%, 720.6%, and 718.1% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 19.15% |
| 10 | SeaStar Medical Holding | 12.74 Mn | 5.74 Mn | 561,000.00 | -616.42% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -616.42% |
| Mar 31, 2026 | -720.60% |
| Dec 31, 2025 | -718.10% |
| Sep 30, 2025 | -1,955.74% |
| Jun 30, 2025 | -519.53% |
| Mar 31, 2025 | -1,274.00% |
| Dec 31, 2024 | -7,114.93% |
| Sep 30, 2024 | -6,552.94% |